Navigation Links
Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Date:12/7/2012

CARLSBAD, Calif., Dec. 7, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from Phase 1 studies of three drugs, ISIS-PTP1BRx, ISIS-GCGRRx and ISIS-GCCRRx, in development to treat metabolic disorders, including type 2 diabetes.  In all three Phase 1 studies, the drugs were safe and well tolerated with early encouraging data that supports the unique mechanism of each drug. All three drugs are part of Isis' metabolic franchise and are designed to act through distinct mechanisms to improve insulin sensitivity and/or reduce glucose production. 

"Our goal is to develop safe, effective drugs with unique mechanisms of action that can provide significant therapeutic benefit for patients with metabolic disorders, including type 2 diabetes. This year we have moved closer to this goal with the completion of our initial clinical studies on three promising drugs from our metabolic franchise.  These drugs are uniquely positioned to fill the critical voids in diabetes therapy," said Stanley T. Crooke, M.D., Ph.D., chief executive officer at Isis.  "While these drugs may be beneficial as single agents, our goal is to develop them as adjuncts to existing diabetes therapies.  We believe that each drug has the potential to address a distinct and significant commercial market in patients with type 2 diabetes."

ISIS-PTP1BRx
ISIS-PTP1BRx targets protein tyrosine phosphatase-1B (PTP-1B) and is designed to increase the body's sensitivity to insulin, resulting in better glucose control for patients with type 2 diabetes.  Because of its unique mechanism, ISIS-PTP1BRx has the potential to help patients achieve glucose control without weight gain or hypoglycemia.  In the Phase 1 study of ISIS-PTP1BRx in obese healthy volunteers, I
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
3. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
5. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
7. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
8. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
9. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
10. Cadence Pharmaceuticals to Host Analyst and Investor Day
11. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Integrated Silicon Solution, Inc. (Nasdaq: ... IC solutions, today announced that it will host its ... 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to ... third quarter ended June 30, 2014. To ... 6:50 a.m. Pacific time on July 24, 2014.  The ...
(Date:7/10/2014)... Ariz. , July 10, 2014   Ventana ...  Group, today announced it has entered into an agreement ... which operates as EMD Serono in the ... , to collaborate with Merck KGaA,s biopharmaceutical division on ... for an undisclosed target using Ventana,s proprietary diagnostic assays. ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
(Date:7/10/2014)... News) -- Nature, not nurture, may play the bigger ... new study finds. "As is the case in ... abilities in chimpanzees," William Hopkins of the Yerkes National ... release from the journal Current Biology . ... of intelligence in humans, Hopkins, team said. According ...
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Adults with ... physically abused as children or teenagers than people who ... study. Dyslexia, which affects up to 10 ... Researchers found that 35 percent of adults with this ... compared to 7 percent of those without dyslexia. ...
(Date:7/10/2014)... Kristen Fischer HealthDay Reporter ... help ease the hot flashes that often accompany menopause, new ... than 50 percent of menopausal women, said Dr. Taraneh Shirazian, ... at the Icahn School of Medicine at Mount Sinai Hospital ... more than 10 hot flashes a day, and she added ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... the Twitter wars that break out regularly between outspoken celebrities ... for your own relationship, a new study suggests. High ... couple, even if the couple is in a long-term relationship, ... users. In turn, that friction can lead to cheating ...
(Date:7/10/2014)... response to today,s announcement that the "Mississippi Baby," believed ... been found to have detectable levels of the virus, ... in this setback but remains hopeful that the scientific ... undetectable for more than two years will continue to ... develop a cure. , "Although we had high ...
Breaking Medicine News(10 mins):Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2
... August 2-3, CHICAGO, June 30 From ... nurses and related professionals play a critical,role in ... The Dermatology Nurses, Association (DNA) will offer dermatology,professionals ... formats and,the profession,s best networking opportunities during the ...
... Heart,Association has set August for the premier of Circulation: ... titles to be published,under the banner of Circulation: Journal ... by Lippincott Williams & Wilkins, a part of,Wolters Kluwer ... editor of the new journal. Faxon,is director of strategic ...
... included as part of company,s, comprehensive Pressure Ulcer Prevention Program ... ... MUNDELEIN, Ill., June 30 Medline Industries, Inc.,announced today ... pads and stretcher pads aimed at helping,hospitals and long-term care ...
... the development, marketing and sale of proprietary, patent-pending nutraceutical products, including ... is launching a new pet health care division. , ... ... -- The pet health care division is designed to expand ...
... Results of 2008 World Safety Declaration Survey, ... across organizations, extending it beyond the workplace and ... collaboration and sharing are critical,for keeping employees safe, ... World Safety Declaration (WSD)., The survey results ...
... Robbins & Myers, Inc.,(NYSE: RBN ) today reported ... fiscal third quarter ended May 31, 2008, including $0.14 ... the sale of two product lines in March 2006. ... year period to $0.62,primarily due to higher sales, operating ...
Cached Medicine News:Health News:4th Annual Dermatology Nurses' Association Summer Meeting to Arrive in Windy City 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 3Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 4Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News: University Health Industries Launches Natural Pet Health Care Division 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 4Health News:Robbins & Myers Reports Record Third Quarter Results 2Health News:Robbins & Myers Reports Record Third Quarter Results 3Health News:Robbins & Myers Reports Record Third Quarter Results 4Health News:Robbins & Myers Reports Record Third Quarter Results 5Health News:Robbins & Myers Reports Record Third Quarter Results 6Health News:Robbins & Myers Reports Record Third Quarter Results 7Health News:Robbins & Myers Reports Record Third Quarter Results 8Health News:Robbins & Myers Reports Record Third Quarter Results 9Health News:Robbins & Myers Reports Record Third Quarter Results 10
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: